INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,288 | -88.9% | 20,802 | -57.2% | 0.00% | – |
Q2 2022 | $84,000 | -57.1% | 48,608 | +77.2% | 0.00% | -100.0% |
Q3 2021 | $196,000 | -75.1% | 27,433 | -67.7% | 0.00% | -66.7% |
Q2 2021 | $786,000 | +7.1% | 84,837 | +2.3% | 0.00% | -40.0% |
Q4 2020 | $734,000 | +121.1% | 82,916 | +189.9% | 0.01% | +25.0% |
Q3 2020 | $332,000 | -61.6% | 28,599 | -10.9% | 0.00% | -71.4% |
Q2 2020 | $865,000 | +234.0% | 32,094 | -7.8% | 0.01% | +100.0% |
Q1 2020 | $259,000 | +156.4% | 34,807 | +1.2% | 0.01% | +600.0% |
Q2 2019 | $101,000 | +83.6% | 34,385 | +133.2% | 0.00% | 0.0% |
Q1 2019 | $55,000 | -49.1% | 14,747 | -45.4% | 0.00% | 0.0% |
Q4 2018 | $108,000 | +16.1% | 27,011 | +61.9% | 0.00% | 0.0% |
Q3 2018 | $93,000 | -83.7% | 16,680 | -88.5% | 0.00% | -87.5% |
Q2 2018 | $569,000 | +77.8% | 145,093 | +87.3% | 0.01% | +33.3% |
Q4 2017 | $320,000 | +158.1% | 77,450 | +314.9% | 0.01% | +100.0% |
Q1 2017 | $124,000 | -52.7% | 18,669 | -50.6% | 0.00% | -72.7% |
Q4 2016 | $262,000 | +55.0% | 37,819 | +108.9% | 0.01% | 0.0% |
Q3 2016 | $169,000 | -58.5% | 18,100 | -70.1% | 0.01% | -75.6% |
Q4 2015 | $407,000 | +535.9% | 60,600 | +445.9% | 0.04% | +181.2% |
Q3 2015 | $64,000 | – | 11,100 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|